Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) by Seini Moimoi | Jul 17, 2020 | Portfolio News
Inozyme Pharma Acquires ENPP1 Deficiency Program Assets from Alexion Pharmaceuticals by Seini Moimoi | Jul 17, 2020 | Portfolio News
Poseida Therapeutics Appoints Harry J. Leonhardt, Esq. as General Counsel by Seini Moimoi | Jul 16, 2020 | Portfolio News
Axonics® to Report Second Quarter 2020 Results on August 6 by Seini Moimoi | Jul 16, 2020 | Portfolio News
Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19 by Seini Moimoi | Jul 14, 2020 | Portfolio News
